Better Genetic Testing Guidelines Needed to Identify More At-Risk Patients Managed Care Executive, September 25, 2019

Main|Search|PHGKB




Last Posted: Sep 26, 2019

---

• Better Genetic Testing Guidelines Needed to Identify More At-Risk Patients
  Managed Care Executive, September 25, 2019
• Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European.
  Ndugga-Kabuye Mesaki K et al. Familial cancer 2019 Sep
• Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
  Casasanta Nicole et al. Clinical breast cancer 2019 Aug
• Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
  Greenberg Samantha et al. Cancer medicine 2019 Sep
• STELO: a new tool for family physicians for the correct identification of inherited cancer syndromes.
  Mariani Chiara et al. Family practice 2019 Sep
• Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study.
  Rashid Muhammad Usman et al. Hereditary cancer in clinical practice 2019 1727
• Should You Get Genetic Testing for Cancer Risk?
  American Cancer Society, September 18, 2019
• Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.
  Dumbrava E Ileana et al. JCO precision oncology 2019 3
• Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
  Snowsill Tristan M et al. PloS one 2019 14(8) e0221419
• Universal Genetic Testing for All Breast Cancer Patients.
  Copur Mehmet Sitki et al. Oncology (Williston Park, N.Y.) 2019 Aug 33(8)

more